Levi Garraway (Genentech)
Roche releases more Evrysdi data leading up to FDA decision for very young infants with SMA
One month away from an FDA decision on Evrysdi for infants under two months old, Roche’s Genentech has released new long-term data on its oral …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
